Behavioral activity of 1S,3R-ACPD, an agonist of metabotropic glutamate receptors

Polish Journal of Pharmacology

Volumn 49, Issue 4, 1997, Pages 239-248

  Zalewska, Alicja ^a   Wiśniewski, Konstanty ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

1S3R ACPD; Learning; Locomotor activity; Memory; Metabotropic receptors; Rats

Indexed keywords

1 AMINO 1,3 CYCLOPENTANEDICARBOXYLIC ACID; GLUTAMATE RECEPTOR AGONIST; METABOTROPIC RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LEARNING; LOCOMOTION; MALE; MEMORY; NONHUMAN; RAT;

ANIMALS; APOMORPHINE; AVOIDANCE LEARNING; CATALEPSY; CYCLOLEUCINE; HALOPERIDOL; INJECTIONS, INTRAVENTRICULAR; MALE; MEMORY; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; RECEPTORS, METABOTROPIC GLUTAMATE; STEREOTYPED BEHAVIOR;

EID: 1842326157     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. 2+ signal transduction. J. Biol. Chem., 1992, 267, 13361-13368.
2. Ader R., Weijnen J. A. W. M., Moleman P.: Retention of passive avoidance responses as a function of the intensity and duration of electric shock. Psychon. Sci., 1972, 26, 125-130.
3. Aniksztejn L., Bregestovski P., Ben-Ari Y.: Selective activation of quisqualate metabotropic receptor potentiates NMDA but not AMPA responses. Eur. J. Pharmacol., 1991, 205, 327-328.
4. Aniksztejn L., Otani S., Ben-Ari Y.: Quisqualate metabotropic receptors modulate NMDA currents and facilitate induction of long-potentiation through protein kinase C. Eur. J. Neurosci., 1992, 4, 500-505.
5. Bashir Z. I., Bortolotto Z. A., Davies C. H., Beretta N., Seal A. J., Henley J. M., Jane D. E., Watkins J. S., Collingridge G. L.: Induction of LTP in the hippocampus needs synaptic activation of glutamate metabotropic receptors. Nature, 1993, 363, 347-350.
6. Burke J. P., Hablitz J. J.: Presynaptic depression of synaptic transmission mediated by activation of metabotropic glutamate receptors in rat neocotrex. J. Neurosci., 1994, 14, 5120-5130.
7. Calabresi P., Mercuri N. B., Bernardi G.: Activation of quisqualate metabotropic receptors reduces glutamate and GABA-mediated synaptic potentials in the rat striatum. Neurosci. Lett., 1992, 139, 41-44.
8. Campbell A., Werschel M., Cohen B. M., Baldessarini R. J.: Tissue levels of haloperidol by radioreceptor assay and behavioral effects of haloperidol in the rat. Life Sci., 1987, 27, 633-640.
9. Chavis P., Shinozaki H., Bockaert J., Fagni L.: The metabotropic glutamate receptor types 2/3 inhibit L-type calcium channels via a pertussis toxin-sensitive G-protein in cultured cerebellar granule cells. J. Neurosci., 1994, 14, 7067-7076.
10. Collingridge G. L.: The mechanism of induction of NMDA receptor-dependent long-term potentiation in the hippocampus. Exp. Physiol., 1992, 77, 771-797.
11. Cotman C. W., Iversen L. L.: Excitatory amino acids in the brain - focus on NMDA receptors. Trends Neurosci., 1987, 10, 263-265.
12. Curtis D. R., Philips J. W., Watkins J. C.: The excitation of spinal neurones by certain amino acids. J. Physiol. -London, 1960, 150, 656-682.
13. Desai M. A., Smith T. S., Conn P. J.: Multiple metabotropic glutamate receptors regulate hippocampal function. Synapse, 1992, 12, 206-213.
14. Dill R. E., Costa E.: Behavioral dissociation of the enkephalinergic systems of nucleus accumbens and nucleus caudatus. Neuropharmacology, 1977, 16, 232-326.
15. East S. J., Hill M. P., Brotchie J. M.: Metabotropic glutamate receptor agonists inhibit endogenous glutamate release from rat striatal synaptosomes. Eur. J. Pharmacol., 1995, 277, 117-121.
16. Ennaceur A., Delacour J.: Effect of combinated or separate administration of piracetam and choline on learning and memory in the rat. Psychopharmacology, 1987, 92, 58-67.
17. Fonnum F.: Glutamate: a neurotransmitter in mammalian brain. J. Neurochem., 1984, 42, 1-11.
18. Hayashi Y., Tanabe Y., Aramori I., Masu M., Shimamoto K., Ohfune Y., Nakanishi S.: Agonist analysis of 2-(carboxycyclopropyl) glycine isomers for cloned metabotropic glutamate receptor subtypes expressed in chinese hamster ovary cells. Brit. J. Pharmacol. 1992, 107, 539.
19. Ishida M., Saitoh T., Nakamura Y., Kataoka K., Shinozaki H.: A novel metabotropic glutamate receptor agonist: (2S,1′S,2′R,3′R)-2-(2-carboxy-3-methoxymethylcyclopropyl) glycine (cis-MCG-I). Eur. J. Pharmacol., 1994, 268, 267-270.
20. Kemp M., Jane D. E., Tse H.-W., Roberts P. J., Watkins J. C.: Novel agonists and antagonists of rat forebrain metabotropic glutamate receptors negatively coupled to adenylyl cyclase. Brit. J. Pharmacol., 1994, 112 Proc. Suppl., 634P.
21. Kennedy L. A., Zigmond M. J.: The behavioral effects of D-amphetamine are correlated with its effects on cAMP in different brain regions. Brain Res., 1979, 168, 408-413.
22. Kesner R. P., Bolland B. L., Dakis M.: Memory for spatial locations, motor responses, and objects: triple dissociation among the hippocampus, caudate nucleus, and extrastriate visual cortex. Exp. Brain Res., 1993, 93, 462-470.
23. Klemm W. R.: Evidence for a cholinergic role in haloperidol-induced catalepsy. Psychopharmacology, 1985, 85, 139-142.
24. Klitgaard N., Laudrup P.: Metabotropic excitatory amino acid receptor agonists selectively potentiate behavioral effects induced by ionotropic excitatory amino acid receptor agonists in mice. Eur. J. Pharmacol., 1993, 250, 9-13.
25. Kretschmer B. D., Zadow B., Voltz T. L., Voltz L., Schmidt W. J.: The contribution of the different binding sites of the N-methyl-D-aspartate (NMDA) receptor to the expression of behavior. J. Neural Transm. [Gen. Sect.], 1992, 87, 23-35.
26. Laudrup P., Klitgaard H.: Metabotropic and ionotropic excitatory amino acid receptor agonists induce different behavioral effects in mice. Eur. J. Pharmacol., 1993, 250, 15-22.
27. Masu M., Tanabe Y., Tsuchida K., Shigemoto R., Nakanishi S.: Sequence and expression of metabotropic glutamate receptor. Nature, 1991, 349, 760-765.
28. McGaugh J. L., Dawson R.: Modification of memory storage processes. Behav. Sci., 1977, 16, 45-63.
29. Monaghan D. T., Ridges R. J., Cotman C. W.: The excitatory amino acid receptor: their classes, pharmacology and distinct properties in the function of the central nervous system. Annu. Rev. Pharmacol. Toxicol., 1989, 29, 365-402.
30. Mondadori C., Ortmann R., Petschke F., Buerki H., D'Amato F., Meisburger J. G., Fagg G. E.: Task-dependent impairment or facilitation of learning by NMDA receptor blockade. In: Frontiers in Excitatory Amino Acid Research. Eds. Cavalheiro E. A., Lehmann J., Turski L., Liss Inc., New York, 1988, 419-426.
31. Mondadori C., Weiskrantz L.: NMDA receptors blockers facilitate and impair learning via different mechanisms. Behav. Neurol. Biol., 1993, 60, 205-210.
32. Nakagawa Y., Saitoh K., Ishihara T., Ishida M., Shinozaki H.: (2S,3S,4S) Alpha-(carboxycyclopropyl)glycine is a novel agonist of metabotropic glutamate receptors. Eur. J. Pharmacol., 1990, 184, 205-206.
33. Nakanishi S.: Molecular diversity of glutamate receptors and implications for brain function. Science, 1992, 258, 597-603.
34. Okamoto N., Hori S., Akazawa C., Hayashi Y., Shigemoto R., Mizuno N., Nakanishi S.: Molecular characterization of a new metabotropic glutamate receptor mGluR7 coupled to inhibitory cyclic AMP signal transduction. J. Biol. Chem., 1994, 269, 1231-1236.
35. Pin J.-P., Duvoisin R.: The metabotropic glutamate receptors: structure and functions. Neuropharmacology, 1995, 34, 1-26.
36. Pin J.-P., Joly C., Heinemann S. F., Bockaert J.: Domains involved in the specificity of G protein activation in phospholipase C-coupled metabotropic glutamate receptors. EMBO J., 1994, 13, 342-348.
37. Poncer J. C., Miles R.: Distinct metabotropic receptors modulate synaptic inhibition in the rat hippocampus. J. Physiol. - London, 1994, 480P, 26-27.
38. Salt T. E., Eaton S. A.: Modulation of sensory neurone excitatory and inhibitory responses in the ventrobasal thalamus by activation of metabotropic excitatory amino acid receptors. Neuropharmacology, 1995, 34, 1043-1052.
39. Scatton B.: The NMDA receptors complex. Fundam. Clin. Pharmacol., 1993, 7, 389-400.
40. Schoepp D. D., Bockaert J., Sladeczek F.: Pharmacological and functional characteristics of metabotropic excitatory amino acid receptors. Trends Pharmacol. Sci., 1990, 11, 508-515.
41. Schoepp D. D., Conn P. J.: Metabotropic glutamate receptors in brain function and pathology. Trends Pharmacol. Sci., 1993, 14, 13-20.
42. Schoepp D. D., Johnson B. G., Salhoff C. R., McDonald J. W., Johnston M. V.: In vitro and in vivo pharmacology of trans-and cis-(±)-1-amino-1,3-cyclopentanedicarboxylic acid: dissociation of metabotropic and ionotropic excitatory amino acid receptor effects. J. Neurochem., 1991, 56, 1789-1796.
43. Siliprandi R., Lipartiti M., Fadda E., Sautter J., Manev H.: Activation of the glutamate metabotropic receptor protects retina against N-methyl-D-aspartate toxicity. Eur. J. Pharmacol., 1992, 219, 173-174.
44. Statman D., Chen C. K., Johnston M. V., Fisher S., Uckele J., Silverstain F. S.: Excitotoxic brain injury enhances quisqualic acid-stimulated phosphoinositide turnover. Ann. Neurol., 1988, 24, 349-350.
45. Sugiyama H., Ito J., Hirono C.: A new type of glutamate receptof linked to inositol phospholipid metabolism. Nature, 1987, 325, 531-533.
46. Tanabe Y., Masu M., Ishii T., Shigemoto R., Nakanishi S.: A family of metabotropic glutamate receptors. Neuron, 1992, 8, 169-179.
47. Tanabe Y., Nomura A., Masu M., Shigemoto R., Mizuno N., Nakanishi S.: Signal transduction, pharmacological properties and expression patterns of two rat metabotropic glutamate receptors, mGluR3 and mGluR4. J. Neurosci., 1993, 13, 1372-1378.
48. Thomsen C., Kristensen P., Mulvihil E., Haldeman P., Suzdak P. D.: L-2-amino-4-phosphonobutyrate (L-AP4) is an agonist at the type IV metabotropic glutamate receptor which is negatively coupled to adenylate cyclase. Eur. J. Pharmacol. - Molec. Pharm., 1992, 227, 361-362.
49. Tizzano J. P., Griffey K. I., Johnson J. A., Fix A. S., Helton D. R., Schoepp D. D.: Intracerebral 1S,3R-1-aminocyclopentane-1,3-dicarboxylic acid (1S,3R-ACPD) produces limbic seizures that are not blocked by ionotropic glutamate receptor antagonist. Neurosci. Lett., 1993, 162, 12-16.
50. Wan H., Cahusac P. M. B.: The effects of L-AP4 and L-serine-O-phosphate on inhibition in primary somatosensory cortex of the adult rat in vivo. Neuropharmacology, 1995, 34, 1053-1062.
51. Winnicka M. M., Wiśniewski K., Kupczyk-Subotkowska L., Subotkowski W., Mastalerz P.: Central activity of 2-amino-3-phosphonopropionic acid (AP3) and its N-methyl analog. Pol. J. Pharmacol., 1994, 46, 395-401.
52. Zalewska A., Winnicka M. M., Wiśniewski K.: Central activity of 2-amino-4-phosphonobutyric acid (AP4). Pol. J. Pharmacol., 1995, 47, 9-17.